Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.1M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+3.34M
-
Total reported value, excl. options
-
$7.39M
-
Value change
-
+$1.85M
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$0.56
Significant Holders of BiomX Inc. - Common Stock (PHGE) as of Q1 2025
20 filings reported holding PHGE - BiomX Inc. - Common Stock as of Q1 2025.
BiomX Inc. - Common Stock (PHGE) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 26.1M outstanding shares and own 50.93% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.49M shares), Nantahala Capital Management, LLC (2.49M shares), ORBIMED ADVISORS LLC (1.79M shares), Alyeska Investment Group, L.P. (1.59M shares), AIGH Capital Management LLC (1.57M shares), Allostery Investments LP (941K shares), Ikarian Capital, LLC (893K shares), JPMORGAN CHASE & CO (430K shares), DAFNA Capital Management LLC (401K shares), and ADAR1 Capital Management, LLC (300K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.